Integra LifeSciences Holdings Corporation
Integra LifeSciences Holdings Corporation (IART) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · IART · as of Jun 8, 2026
Key Statistics
Explore Integra LifeSciences Holdings Corporation Data
iart stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 26 · Buy rate: 42.3%
The IART analyst consensus is Buy, based on ratings from 26 Wall Street analysts over the past 3 months. The average 12-month price target is $12.00, representing -29.37% downside from the current price of $16.99.
Competitors & Peers
iart competitorsIART
BCAX
BFLY
EYPT
FTRE
INMDStock Performance
Full HistoryAbout Integra LifeSciences Holdings Corporation
Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments for use in neurosurgery, extremity reconstruction, and general surgery. It opera…
what is integra lifesciences holdings corporation · iart stock overview · integra lifesciences holdings corporation company profile · who is integra lifesciences holdings corporation ceo · iart NASDAQ · integra lifesciences holdings corporation headquarters · integra lifesciences holdings corporation business segments
About Stock Overview & Key Data
Integra LifeSciences Holdings Corporation (IART) is a Healthcare company in the Medical - Devices industry, listed on NASDAQ since Aug 16, 1995. As of the latest trading session, IART stock price is $16.99, with a market capitalization of $1.3B. The stock has returned +22.41% over the past 12 months and +36.80% year-to-date.
According to 26 Wall Street analysts, the consensus rating for Integra LifeSciences Holdings Corporation stock is Buy, with an average 12-month price target of $12.00. In fiscal year 2025, Integra LifeSciences Holdings Corporation reported revenue of $1.6B and net income of -$516.5M. For detailed data — including Integra LifeSciences Holdings Corporation revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Integra LifeSciences Holdings Corporation (IART) stock price is $16.99. The stock is traded on NASDAQ under the ticker symbol IART. The 52-week range is $8.70 – $17.83.